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INTRODUCTION
Immunoglobulin light chain (AL) amyloidosis is the most frequent systemic form in Western countries 1,2 and is caused by aggregation and deposition of monoclonal immunoglobulin light chains (LC) produced by a bone marrow plasma cell clone and transported to target organs through the bloodstream. The clinical picture in this form is heterogeneous and depends on which organs are targeted by fibril deposition. Cardiac involvement is present in up to 75% of patients and is the main prognostic determinant, leading to death for chronic heart failure or fatal arrhythmias 3 .
Chemotherapy, by reducing the circulating amyloidogenic LC through suppression of the plasma cell clone, leads to extended survival and improved organ function 3, 4 . However, its benefits to patients with severe heart dysfunction are minimal, because they are too fragile to receive aggressive treatments and do not survive long enough to benefit from any responses to therapy 5 .
Clinical and experimental observations suggest that in AL amyloidosis, the soluble precursor protein itself may exert direct cardiotoxicity that significantly contributes to organ dysfunction in addition to the damage caused by cardiac infiltration of amyloid fibrils [4] [5] [6] [7] [8] .
Cellular functional alterations, oxidative stress 7-9 and activation of specific signal transduction pathways 8 were found as prominent aberrant features in vitro. Possibly, both host-related factors and intrinsic LC characteristics are required to cause organ toxicity. In vitro data suggest that LC associated with cardiomyopathy have an intrinsic and specific cardiotoxic potential. Although the use of certain LC germline genes has been associated with specific organ targeting 10 , including the heart 11 , no specific features related to LC cardiotoxicity have been described yet, and predicting a protein's ability to target the heart is currently impossible.
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We used Caenorhabditis elegans as in vivo model to investigate the effect of cardiotoxic LC and clarify the underlying mechanisms of toxicity. C. elegans was chosen because its pharynx is considered to be evolutionarily related to the vertebrate heart and its muscle cells have autonomous contractile activity, reminiscent of cardiac myocytes 12 . The rhythmic contraction and relaxation of the nematode's pharyngeal muscle, pharyngeal pumping, is responsible for the ingestion and transport of food from the mouth to the intestine 13 . Stress-induced inhibition of feeding was suggested as an important survival mechanism that limits the intake of toxic solutes. In fact, pharyngeal pumping is inhibited by chemical stressors which induce the production of cellular stress proteins 14 .
We evaluated the effect on pharyngeal pumping of soluble amyloidogenic LC with different organ tropisms from AL patients and non-amyloidogenic LC from multiple myeloma subjects. Only amyloidogenic LC that are cardiotoxic in patients caused a specific impairment of the pharyngeal pumping rate of C. elegans. These manifestations are paralleled by an increase of mitochondrial reactive oxygen species and can be prevented by treatment with antioxidant agents. The data indicate that the nematode-based assay is a promising model for investigating heart-specific toxicity of amyloidogenic LC and for a rapid screening of the potential drugs and novel therapeutic approaches.
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METHODS

Patients' samples
Urine, serum and bone marrow plasma cells were obtained from patients during routine diagnostic procedures at the Amyloid Research and Treatment Center, Foundation IRCCS Policlinico San Matteo (Pavia, Italy). Acquisition, storage and use of biological samples were approved by the Institutional Review Board. Written informed consent was received from participants prior to inclusion in the study. The study was conducted in accordance with the Declaration of Helsinki. The presence of tissue amyloid deposits and amyloid organ involvement were defined according to the International Consensus Panel Criteria 15, 16 . LC cardiotoxicity was evaluated on the basis of clinical, instrumental (echocardiography) and biochemical parameters 17 . The clinical characteristics of the patients included in the study are reported in Table 1 .
Human monoclonal amyloidogenic cardiotoxic LC (H), amyloidogenic non-cardiotoxic LC and non-amyloidogenic LC from multiple myeloma patients without amyloidosis (MM) were isolated from 24 h urine collected from patients (Bence Jones, BJ) and/or from serum (s) or produced, as recombinant proteins (r), in a bacterial system (see Supplemental Methods). The homogeneity of all the purified LC was assessed by 12% SDS PAGE and Western blot. In addition, mass spectrometry analysis, physicochemical studies and the examination of the oligomerization state were performed on prototypic proteins, i.e.
recombinant cardiotoxic (H3-r) and non-cardiotoxic (K3-r) amyloid proteins and on BJ proteins purified from urine of a patient suffering from AL cardiomyopathy (H6-BJ) and from a patient with multiple myeloma (MM2-BJ) (see Supplemental Methods) 18 . The biochemical characteristics of these proteins (e.g. size, molecular mass and calculated Worms were incubated with 1-200 μ g/ml BJ or recombinant LC (100 worms/100 μ l) in 10 mM PBS, pH 7.4, or with 50 μ g/ml free LC from patients' serum, in 5 mM PBS, pH 7.4 (100 worms/100 μ l). Control worms were incubated with 10 mM PBS, pH 7.4 (vehicle) only. The effect of eluate obtained from incubation of anti-free LC antibodies with serum of healthy donors was also considered. After 2 h, worms were transferred onto NGM plates seeded with OP50 E. coli. The pharyngeal pumping rate, measured by counting the number of times the terminal bulb of the pharynx contracted over a 1-minute interval, was scored from 2 h up to 48 h later. The pumping rate of worms treated with the eluate obtained from serum of healthy donors was not different from vehicle treated ones (data not shown). For this reason, 10 mM PBS, pH 7.4, was used as vehicle for all the experiments. To visualize the effect of LC on the pumping rate, the feeding assay was performed by monitoring the ability of worms to ingest multifluorescent beads (Supplemental Methods). The effect of LC administration on pharyngeal cell viability was determined using the cellimpermeable dye propidium iodide, which can be fed to C. elegans (Supplemental Methods).
In selected experiments, worms were fed for 2 h with 100 μ g/ml of H6-BJ alone or with the prototypic antioxidants N-acetyl-cysteine (NAC, 0.1-20 mM, Sigma-Aldrich) and L-ascorbic acid (5-568 μ M, Sigma-Aldrich) in 5 mM PBS, pH 7.4. The effect of tetracycline hydrochloride (TETRA, 5-100 μ M, Sigma-Aldrich) and epigallocathechin gallate (EGCG, 0.1-1000 μ M, kindly provided by Indena, Italy), in 5 mM PBS, pH 7.4, both known to possess antioxidant properties, was also considered. Higher doses of drugs proved toxic for nematodes. The effect of 0.1 mM H 2 O 2 for 30 min was also investigated. Worms were then transferred onto fresh NGM plates seeded with E. coli in the presence of the same drug concentration and the pharyngeal pumping rate was scored after 20 h. Worms were also exposed to the drugs alone or to vehicle in the same conditions.
For lifespan experiments, L3 larval stage worms were fed for 2 h with: a) 100 μ g/ml of MM2-BJ or 100 μ g/ml H6-BJ; b)100 μ g/ml H6-BJ plus the optimal dose of an antioxidant compound (5 mM NAC, 284 µM ascorbic acid, 50 µM TETRA or 100 µM EGCG); c) the optimal dose of antioxidant compound alone. Then nematodes were transferred onto fresh NGM plates seeded with E. coli in the presence of the same drug concentration. Control worms were exposed, under the same conditions, to vehicle alone. After 20 h nematodes were transferred to fresh NGM plates seeded with bacteria and the number of live worms was scored (considered as day 0). To avoid overlapping generations, the worms were then transferred every day, in the absence of fluorodeoxyuridine, on NGM plates seeded with E. coli in the presence or absence of 5 mM NAC, 284 µM ascorbic acid, 50 µM TETRA or 
Mitochondrial production of reactive oxygen species (ROS)
The effect of LC on mitochondrial oxidant burden was evaluated by feeding worms with
MitoSOX Red (Molecular Probes, Italy) 23, 24 . Worms, L3-L4 larval stage, were incubated for 2 h with 100 µg/ml of MM2-BJ, H6-BJ, H3-r or K3-r, as described above. Negative control worms were fed vehicle alone whereas positive controls were fed 0.1 mM H 2 O 2 to induce oxidant stress. To investigate the effect of antioxidant on mitochondrial ROS production, worms were incubated for 2 h with 100 µg/ml H6-BJ or for 30 min with 0.1 mM H 2 O 2, in the absence or presence of 5 mM NAC, 284 μ M L-ascorbic acid, 50 μ M TETRA or 100 μ M EGCG. The effect of drug alone was also determined. Nematodes were then transferred to NGM plates seeded with fresh bacteria as food and 10 µM MitoSOX Red.
After 20 h, nematodes were transferred to fresh NGM plates seeded with OP50 and left for 1 h, so that residual dye could be washed out from the pharynx lumen. Nematodes were paralyzed with 1 mM levamisole, transferred to tubes containing 1 ml of M9 plus 1 mM levamisole, centrifuged and fixed in 4% paraformaldehyde in 5 mM PBS, pH 7.4, for 24 h at 4°C. Worms were then mounted on slides for microscopy and were observed by epifluorescence using an inverted fluorescent microscope (IX-71 Olympus) equipped with a CCD camera.
Statistical analysis
The data were analyzed using GraphPad Prism 4.0 software (CA, USA) by an independent Student's t-test and one-way ANOVA and Bonferroni's post-test analysis. Proteins were administered to worms for 2 h at 100 µg/ml, which is the representative concentration of circulating levels of free LC in AL patients, and were then plated on NGM plates seeded with OP50 E. coli. These experimental conditions did not affect the physiological pharyngeal contraction of worms
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; in fact, the pumping rate of C. elegans incubated with vehicle, without bacteria (235.0 ± 3.6 pumps/min, N=30), as determined 2 h after plating, was not different from untreated ones which fed OP50 seeded on the plate for the same time (225.4±5.1 pumps/min, N=30).
The pharyngeal pumping of LC fed nematodes was scored at different times after plating worms on NGM plates seeded with bacteria. After 2 h, the pumping rate of H6-BJ-fed worms was already significantly reduced compared to vehicle-fed ones and a comparable inhibition was observed for up to 48 h ( Figure 1A ). This reduction in pumping motion was not accompanied by a modification of the worms' viability. Feeding worms with the nonamyloidogenic MM2-BJ did not cause reduction in the pumping rate nor affected the viability for every interval considered ( Figure 1A ). Therefore, cardiotoxic LC caused a The inhibition to the pumping rate caused by H6-BJ was dose-dependent in the range of concentrations from 2.5 to 200 µg/ml, whereas MM2-BJ was not effective ( Figure 1B ). The effect of H6-BJ was significant from 10 µg/ml and reached the maximum at 100 µg/ml ( Figure 1B) . The pumping impairment caused by this protein concentration was visualized by evaluating the ability of worms to ingest fluorescent beads ( Figure 1C and Supplemental Methods). In the pharynx of H6-BJ fed worms a strong reduction of the steady-state fluorescent signal was observed, compared to vehicle-fed animals ( Figure   1C ) indicative of a pumping impairment.
To further exclude the chance that the different toxicity observed in the above described experiments could be attributed only to extensive differences in the LC primary sequences, we also compared the effects of two recombinant proteins derived from patients with severe amyloid cardiomyopathy (H3-r) or overt nephrotic syndrome and renal insufficiency (K3-r) ( Table 1 ). These two selected LC derived from the rearrangement of the same IGLV1-44 germline gene, associated with a 5-fold increase in the odds of dominant heart involvement in AL amyloidosis 11 and have ∼94% amino acid identity. Although both proteins proved able to inhibit the pumping rate, H3-r was more effective than K3-r at concentrations above 10 µg/ml ( Figure 1D ).
Notably, urinary and recombinant cardiotoxic LC had very similar effects on C. elegans pharynx, as indicated by the shape of the dose-response curves and IC 50 values obtained (3.9± 1.2 µg/ml and 5.6 ± 2.1 µg/ml, for H6-BJ and H3-r, respectively, p= 0.294, Student's t-test) ( Figure 1E ). Figure 2 ). BJ proteins were tested at 100 µg/ml: LC that are cardiotoxic to patients significantly impaired the pumping rate of nematodes (191.0±3.5 and 225.0±3.0 pumps/min for cardiotoxic LC and vehicle fed worms, respectively, p<0.001, one-way ANOVA), whereas no effect was observed with LC from subjects affected by amyloidosis involving organs other than the heart (e.g. kidney) (226.5±1.5 pumps/min, p<0.01 vs. cardiotoxic LC, one-way ANOVA) or with multiple myeloma (228.2±4.0 pumps/min, p<0.01 vs. cardiotoxic LC, one-way ANOVA) ( Figure 2A ). The impairment of pharyngeal pumping caused by LC purified from patients' serum was then explored.
Despite the lower dosage used (50 µg/ml), due to reduced recovery of LC from serum 25 , the specific effect of cardiotoxic LC was also observed in this experimental setting (190.1.0±2.0 and 207.2±2.0 pumps/min for cardiotoxic LC and vehicle fed worms, respectively, p<0.001, one-way ANOVA) ( Figure 2B ). Similarly, cardiotoxic LC (100 µg/ml), produced as recombinant proteins in a bacterial system, caused a significant pumping rate reduction (186.7±1.5 and 225.3±23.0 pumps/min for cardiotoxic LC and vehicle fed worms, respectively, p<0.001, one-way ANOVA) ( Figure 2C ). Overall, these data indicate that cardiotoxic LC obtained from different patients specifically trigger a pharyngeal dysfunction in C. elegans independent of their origin: serum, urine or recombinant.
To determine whether the impairment of pumping function caused by cardiotoxic LC may be related to a reduction of viable cells in the pharynx, worms were fed propidium iodide, a fluorescent dye that enters and stains dead cells (Supplemental Materials). In the pharynx region of H6-BJ fed worms, but not in the control ones, we observed a red fluorescencepositive signal due to staining of dead cells (Supplementary Figure 6D ). This cell death Figure 6F) which caused a significant impairment of the pharyngeal pumping rate (226.7 ±2.0 and 190.1 ±1.0 pumps/min for vehicle and H 2 O 2 fed worms respectively; p<0.01 one-way ANOVA, N=30 worms/group).
Recent data indicated that soluble LC caused a marked reduction in the lifespan of zebrafish 26, 27 . We then analyzed whether the pharyngeal dysfunction induced by cardiotoxic LC could affect, in time, nematode survival. The administration of H6-BJ, but not MM2-BJ, significantly reduced the worm's survival (median survival: 14 days for vehicle; 9 days for H6-BJ, p=0.024 vs. vehicle, Log-rank test; 14 days for MM2-BJ, p=0.072 vs. H6-BJ and p=0.53 vs. vehicle, Log-rank test) ( Figure 3A ).
Functional damage caused by cardiotoxic LC is related to their ability to generate oxygen
radicals. We investigated whether the ability of cardiotoxic LC to reduce the pharyngeal muscular pumping of the nematodes was related to their propensity to form specific, partially folded intermediates, i.e. small, soluble oligomeric assemblies. The physicochemical properties and the oligomerization state of the above described recombinant and BJ proteins were considered (see Supplemental Methods). The electrophoretic data, Western blot and mass spectrometry analysis indicated that these LC . These data indicated that the ability of cardiotoxic LC to specifically impair the nematode's pharynx contraction was not related to a peculiar protein stability, assembly as well as to differences in hydrophobic regions exposure.
We then explored whether LC toxicity can be related to their propensity to produce ROS 7, 8, 28 thus triggering an oxidative damage. Oxygen free radicals produced by MM2-BJ, H6-BJ, H3-r and K3-r were detected by electron paramagnetic resonance (Supplemental Methods and Supplementary Figure 7 ) and the spectra obtained indicated that cardiotoxic LC exhibited a markedly different behaviour compared to non-cardiotoxic ones. In particular, H6-BJ produced a greater amount of OH and 2OH radical species than MM2-BJ (Supplementary Figure 7) . Notably, whereas the tiny amount of radicals produced by noncardiotoxic LC quickly disappeared, cardiotoxic proteins continuously generate oxygen radicals ( Supplementary Figure 7) , which are known stressors, causing the pharyngeal pumping inhibition in C. elegans.
To further explore the oxidative stress pathogenic hypothesis, we next investigated mitochondria, to clarify whether the stressful condition generated by cardiotoxic LC in C.
elegans' pharynx can result in ROS generation within its sub-cellular compartments. In fact, an excessive production of ROS within mitochondria can induce oxidative damage that may be related to the pharyngeal dysfunction 29 . The pharyngeal pumping dysfunction caused by the cardiotoxic H6-BJ and H3-r proteins was accompanied by a significant increase in the fluorescence of MitoSOX, a mitochondria-specific redox-sensitive dye, indicative of an enhanced oxidant burden ( Figure 3B and Supplementary Figure 8 ). This oxidant level was comparable to that generated by exposing worms to 0. Figure 3B) . Thus, the pharyngeal pumping dysfunction induced by cardiotoxic LC is associated with enhanced mitochondrial ROS production.
These observations prompted us to explore an alternative approach to abolishing or reducing LC toxicity. The effect of the prototypic antioxidants N-acetyl-cysteine (NAC) and ascorbic acid was investigated. We also examined the polyphenolic green tea constituent epigallocathechin gallate (EGCG) and tetracycline hydrochloride (TETRA), both known to possess antioxidant properties 30, 31 . All these compounds reduced the inhibition of pharyngeal pumping caused by H6-BJ in a dose-dependent manner, although with different potency (Figure 4 A-D). The highest IC 50 values were measured for compounds displaying only antioxidant effects (3 ± 1.1 mM and 150 ± 4.5 µM for NAC and ascorbic acid, respectively), whereas EGCG and TETRA had much lower IC 50 (11 ±1.2 µM and 18 ±1.1 µM, for EGCG and TETRA, respectively) ( Figure 4 ). Five mM NAC, 284 µM ascorbic acid or 100 µM EGCG completely abolished the pharyngeal impairment caused by the H6-BJ, whereas 50 µM TETRA significantly counteracted this inhibition but did not reverse it ( Figure 4E ). The ability of all these drugs to neutralize the pumping dysfunction caused by cardiotoxic LC was accompanied by a strong reduction of ROS generation into pharyngeal mitochondria, as indicated by the inhibition of MitoSOX-related fluorescence ( Supplementary Fig. 9 ). Drugs alone did not affect the pumping rate ( Figure 4E ), nor the increase of pharyngeal mitochondrial oxygen burden (Supplementary Figure 9) . We also investigated whether ROS scavengers prolonged the lifespan of nematodes fed Figure 10) , indicating that the prevention of ROS generation by cardiotoxic LC can modify the overall toxicity of the proteins. However, these protective effects were not observed with repeated administration of 50 µM TETRA or 100 µM EGCG, even at lower doses, because they resulted toxic to worms. These findings are in agreement with the reported anti-helminthic activity of chronic administration of TETRA and EGCG 32, 33 . 
DISCUSSION
Although amyloid deposition is a defining feature of cardiac amyloidosis, the presence of fibrils is not sufficient to explain the cardiotoxicity observed in AL patients 4, 5 . Clinically, the rapid improvement or worsening of cardiac function, which parallels variations in serum LC concentration in the absence of changes in amyloid load, cannot be explained without attributing a toxic role to pre-fibrillar, soluble LC species 4, 5 Interestingly, we observed that toxic LC did not display a peculiar protein folding, nor propensity to form aggregates of a different size compared to the non-toxic LC species.
The lack of differences in oligomerization, secondary structure, stability and surface hydrophobicity between cardiotoxic and non-cardiotoxic LC lead us to hypothesize that toxicity may proceed through common super-secondary structures linked to the proteins' primary sequence. Indeed, the nematode assay proved to be very sensitive and specific in this aspect, being capable of discerning the few amino acid differences of two recombinant LC derived from the same germline gene (IGVL1-44), but with different organ tropism and toxicity ( Figure 1D , K3r, from a patient with kidney involvement, and H3r, from a patient with cardiac dysfunction). This argument is in line with the notion that the LC sequence is a major determinant of specific organ targeting and damage 10,11 . It is noteworthy that C. elegans has previously been employed as a model to study various .
Overall, our work shows that C. elegans can be considered a "biosensor", suitable for a rapid and inexpensive assessment of the cardiotoxic potential of LC. Besides allowing the study of the molecular and functional consequences of exposure to LC, we anticipate its possible use for screening LC cardiotoxicity in basic research and translational applications. As an example, given its sensitivity to small sequence variations ( Figure 1D 
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